American Bio Medica Retains Porter, LeVay & Rose.Business Editors KINDERHOOK, N.Y.--(BUSINESS WIRE)--March 13, 2000 American Bio Medica medica (māˑ·dē·k Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ), which develops, manufactures and markets drugs of abuse diagnostic kits, sprays and support services, including its patented Rapid Drug Screen(TM) and Drug Detector(TM) on-site drug testing devices, announced today that it has retained Porter, LeVay & Rose, Inc. as its investor relations counsel. Porter, LeVay & Rose, Inc. is a 30-year-old, New York City-based public relations firm that represents a wide variety of publicly-held companies and financial institutions in the U. S. and abroad. American Bio Medica and its global distributors offer businesses, schools, law enforcement, physicians, hospitals and clinics the widest range of FDA-approved, on-site drug screens in the industry, and the company plans to develop a portfolio of other products for the $6 billion immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. market. Stan Cipkowski, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of American Bio Medica, said, "We are pleased that Porter, LeVay & Rose will be helping us educate and inform the financial community, our shareholders and the business news media about the company's technologies, products and strategies. Our goal is to heighten the company's visibility and shareholder value as we pursue our ambitious growth plans." |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion